cancer therapy

OncoNano CEO Martin Driscoll [Photo: OncoNano]

OncoNano Expands Research Collaboration With UT Southwestern to Advance New Cancer Therapies

by | Sep 22, 2021
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology. OncoNano raised $50 million in Series B funding in June.
MORE►
A Special Thank you to our sponsors

Dallas Innovates is owned by the Dallas Regional Chamber. Editorial operations are led independently by Lawley Head Media.

© Copyright 2026 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners